Search

everythinglearnresearchcommunity

for

Search:↓

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

The symptoms described align more with Haberland syndrome, not Delleman-Oorthuys syndrome.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

Follicle Stimulating Hormone is important for fertility.

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

Flutamide worked better than finasteride for reducing excessive hair growth in women, but had more side effects.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Spironolactone treatment increases the amount of testosterone available in the body.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

The VVG stain effectively differentiates scar tissue from normal skin and helps classify types of permanent alopecia.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Diane 35 plus finasteride is more effective for treating hirsutism.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Some women with acne have higher levels of free testosterone, which might suggest using hormonal treatments for acne.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.